Cargando…

A novel SART3::RARG fusion gene in acute myeloid leukemia with acute promyelocytic leukemia phenotype and differentiation escape to retinoic acid

Detalles Bibliográficos
Autores principales:	Li, Ji, Zhang, Yang, Li, Junjun, Xu, Yunxiao, Zhang, Guangsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890015/ https://www.ncbi.nlm.nih.gov/pubmed/36300779 http://dx.doi.org/10.3324/haematol.2022.281766

Ejemplares similares

Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration
por: Han, Xiaoyan, et al.
Publicado: (2021)

Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
por: Zhao, Junmei, et al.
Publicado: (2022)

Acute Myeloid Leukemia with NUP98-RARG Gene Fusion Similar to Acute Promyelocytic Leukemia: Case Report and Literature Review
por: Tao, Shandong, et al.
Publicado: (2020)

RARG Gene Dysregulation in Acute Myeloid Leukemia
por: Conserva, Maria Rosa, et al.
Publicado: (2019)

A global study for acute myeloid leukemia with RARG rearrangement
por: Zhu, Hong-Hu, et al.
Publicado: (2023)

Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report
por: Wei, Wei, et al.
Publicado: (2020)

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
por: Ding, Wenjing, et al.
Publicado: (2023)

Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse
por: Gupta, Varsha, et al.
Publicado: (2019)

PB1786: TRINARY FUSION AND LIGAND BINDING DOMAIN TRUNCATION AS RECURRENT AND CRUCIAL MOLECULAR CHARACTERISTICS IN RARG-DRIVEN ACUTE PROMYELOCYTIC LEUKEMIA AND RENDER UNRESPONSIVE TO ALL-TRANS RETINOIC ACID
por: Zhou, Xiaosu, et al.
Publicado: (2023)

A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
por: Chen, Xue, et al.
Publicado: (2019)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
por: Cloobs-Venezia, Maximiliano, et al.
Publicado: (2022)

Mechanical phenotyping reveals unique biomechanical responses in retinoic acid-resistant acute promyelocytic leukemia
por: Li, Brian, et al.
Publicado: (2022)

Chronic myeloid leukemia developing in treated acute promyelocytic leukemia
por: Abbasi, Abdul Muqtadir, et al.
Publicado: (2022)

Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha
por: GAO, NA, et al.
Publicado: (2016)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2018)

Acute Myeloid Leukemia Cells Harboring MLL Fusion Genes or with the Acute Promyelocytic Leukemia Phenotype Are Sensitive to the Bcl-2-selective Inhibitor ABT-199
por: Niu, Xiaojia, et al.
Publicado: (2014)

Transcriptional features of acute leukemia with promyelocytic differentiation lacking retinoic acid receptor rearrangements
por: Su, Zhan, et al.
Publicado: (2023)

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
por: Yuan, Jiaojiao, et al.
Publicado: (2023)

A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia
por: Cheng, Chi-Keung, et al.
Publicado: (2022)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
por: Sahoo, Ranjit Kumar, et al.
Publicado: (2013)

Non‐acute promyelocytic leukemia variant, acute myeloid leukemia with translocation (11;17)
por: Altahan, Rahaf, et al.
Publicado: (2019)

All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
por: Anoop, T. M., et al.
Publicado: (2014)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
por: McCulloch, Derek, et al.
Publicado: (2017)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia
por: Weng, Wenwen, et al.
Publicado: (2023)

Oncogenic role of lncRNA CRNDE in acute promyelocytic leukemia and NPM1-mutant acute myeloid leukemia
por: Ma, Xuefei, et al.
Publicado: (2020)

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
por: Riva, L, et al.
Publicado: (2014)

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
por: Riva, L, et al.
Publicado: (2013)

Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines
por: Ge, Dong-zheng, et al.
Publicado: (2014)

Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias
Publicado: (1990)

SCROTAL ULCERATION FOLLOWING ALL-TRANS RETINOIC ACID THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA
por: Tazi, Illias, et al.
Publicado: (2011)

Sweet’s syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid
por: Park, Chi Jun, et al.
Publicado: (2001)

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
por: Masciarelli, S, et al.
Publicado: (2018)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
Publicado: (2017)

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021)

Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias
por: Poplineau, Mathilde, et al.
Publicado: (2022)

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
por: di Martino, Orsola, et al.
Publicado: (2019)

RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin–proteasome pathway contributes to the reversion of ATRA resistance
por: Yan, Wenzhe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qj0c5qbb3ld4ei5dg31mnh26mb